US Stock MarketDetailed Quotes
CRDF Cardiff Oncology
- 3.920
- +0.650+19.88%
Close Dec 13 16:00 ET
- 3.850
- -0.070-1.78%
Post 20:01 ET
260.75MMarket Cap-4.13P/E (TTM)
4.080High3.450Low3.73MVolume3.600Open3.270Pre Close14.43MTurnover5.91%Turnover RatioLossP/E (Static)66.52MShares6.42052wk High5.28P/B247.52MFloat Cap1.30052wk Low--Dividend TTM63.14MShs Float81.480Historical High--Div YieldTTM19.27%Amplitude0.450Historical Low3.870Avg Price1Lot Size
Cardiff Oncology Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -31.41%-10.46M | -29.42%-9.23M | 10.61%-7.74M | 8.67%-30.89M | 23.97%-7.14M | -6.29%-7.96M | -6.53%-7.13M | 15.51%-8.66M | -46.79%-33.82M | -27.06%-9.39M |
| Net income from continuing operations | -21.83%-11.86M | -5.63%-11.78M | 10.80%-10.01M | -7.07%-41.44M | -7.36%-9.34M | -13.53%-9.73M | -6.77%-11.15M | -2.09%-11.22M | -36.81%-38.7M | 7.89%-8.7M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 100.35%1K | ---- |
| Depreciation and amortization | -5.61%101K | 7.14%105K | 13.33%102K | 68.64%398K | 19.77%103K | 32.10%107K | 157.89%98K | 190.32%90K | -47.67%236K | -23.89%86K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -93.16%139K | --0 |
| Change In working capital | -80.25%202K | -46.11%1.39M | -23.65%1.2M | 1,828.42%6.57M | 179.39%1.39M | 791.22%1.02M | 5.61%2.58M | 270.24%1.57M | 78.76%-380K | -8,660.00%-1.75M |
| -Change in receivables | -351.35%-167K | -111.26%-58K | -210.53%-105K | 304.66%483K | 25.62%-90K | 62.63%-37K | 595.19%515K | 7.95%95K | -9.77%-236K | 14.18%-121K |
| -Change in prepaid assets | -58.19%388K | -21.61%791K | -107.59%-95K | 815.35%3.17M | 95.75%-19K | 6,728.57%928K | -12.94%1.01M | 209.64%1.25M | 78.89%-443K | 67.08%-447K |
| -Change in payables and accrued expense | -100.74%-1K | -38.26%673K | 597.04%1.42M | 110.01%2.83M | 6,000.00%1.4M | 421.43%135K | -20.26%1.09M | --203K | 87.48%1.35M | -98.52%23K |
| -Change in other current assets | 0.72%139K | 28.70%139K | -14.81%138K | 207.96%651K | 122.80%243K | 0.73%138K | -22.30%108K | -13.37%162K | -178.01%-603K | -946.03%-1.07M |
| -Change in other current liabilities | -11.35%-157K | -9.22%-154K | -10.14%-152K | -26.91%-566K | -3.55%-146K | -8.46%-141K | -20.51%-141K | -137.93%-138K | 53.88%-446K | 28.06%-141K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -31.41%-10.46M | -29.42%-9.23M | 10.61%-7.74M | 8.67%-30.89M | 23.97%-7.14M | -6.29%-7.96M | -6.53%-7.13M | 15.51%-8.66M | -46.79%-33.82M | -27.06%-9.39M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -346.90%-9.43M | 22.04%14.02M | -36.74%4.64M | -5.12%36.2M | 93.18%13.56M | -25.99%3.82M | 50.95%11.48M | -60.08%7.33M | 129.02%38.15M | 179.83%7.02M |
| Capital expenditure reported | --0 | --0 | -900.00%-80K | 42.15%-582K | 89.33%-8K | 29.69%-315K | 19.55%-251K | 95.32%-8K | -390.73%-1.01M | 29.91%-75K |
| Net investment purchase and sale | -328.09%-9.43M | 19.43%14.02M | -35.72%4.72M | -5.80%36.78M | 91.25%13.57M | -25.72%4.14M | 49.51%11.74M | -60.40%7.34M | 129.75%39.04M | 181.67%7.1M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --114K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -346.90%-9.43M | 22.04%14.02M | -36.74%4.64M | -5.12%36.2M | 93.18%13.56M | -25.99%3.82M | 50.95%11.48M | -60.08%7.33M | 129.02%38.15M | 179.83%7.02M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 7.43M | 2.06M | 107K | 0 | 0 | 0 | 0 | 0 | -99.79%75K | 0 |
| Net common stock issuance | --7.43M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | --253K | --107K | --0 | --0 | --0 | --0 | --0 | -94.06%75K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --7.43M | --2.06M | --107K | --0 | --0 | --0 | --0 | --0 | -99.79%75K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 31.66%25.5M | 24.25%18.66M | 32.47%21.66M | 36.88%16.35M | -18.61%15.23M | -7.61%19.37M | -25.11%15.02M | 36.88%16.35M | -90.88%11.94M | 42.17%18.72M |
| Current changes in cash | -201.33%-12.46M | 57.24%6.84M | -125.34%-3M | 20.53%5.31M | 370.97%6.42M | -83.99%-4.14M | 376.67%4.35M | -116.40%-1.33M | 103.70%4.4M | -93.94%-2.37M |
| End cash Position | -14.41%13.04M | 31.66%25.5M | 24.25%18.66M | 32.47%21.66M | 32.47%21.66M | -18.61%15.23M | -7.61%19.37M | -25.11%15.02M | 36.88%16.35M | 36.88%16.35M |
| Free cash flow | -26.40%-10.46M | -25.02%-9.23M | 9.77%-7.82M | 9.64%-31.47M | 24.49%-7.15M | -4.26%-8.27M | -5.37%-7.38M | 16.82%-8.67M | -49.82%-34.83M | -26.25%-9.47M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
